Production (Stage)
ESSA Pharma Inc.
EPIX
$1.67
-$0.03-1.77%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.75% | -20.56% | -7.37% | -0.89% | 4.21% |
| Total Depreciation and Amortization | -9.63% | -17.93% | -23.40% | -21.79% | -15.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 175.67% | 168.31% | 41.71% | -21.49% | -52.43% |
| Change in Net Operating Assets | -233.71% | -41.06% | -117.90% | 42.53% | 203.86% |
| Cash from Operations | 2.47% | -0.94% | -14.83% | -4.69% | 4.89% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -75.62% | 1,184.41% | 2,702.40% | 1,166.50% | 490.95% |
| Cash from Investing | -75.62% | 1,184.41% | 2,702.40% | 1,166.50% | 490.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 76.96% | 51.16% |
| Issuance of Common Stock | -90.07% | 238.87% | 1,247.31% | 1,658.05% | 855.17% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -89.22% | 545.04% | 1,461.18% | 1,057.64% | 1,727.98% |
| Foreign Exchange rate Adjustments | -2.13% | 171.88% | 279.17% | -93.90% | -95.03% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -111.34% | 465.12% | 399.50% | 261.62% | 212.99% |